Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy
2020 doctoral thesis by Joshua Lionel Lange at University of Otago
Press Enter · cited answer in seconds
0 sources
Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy
Summary
Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy is a doctoral thesis[1].
Key Facts
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy authored Joshua Lange[2].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's instance of is recorded as doctoral thesis[3].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's publisher is recorded as OUR Archive[4].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's language of work or name is recorded as English[5].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's country of origin is recorded as New Zealand[6].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's publication date is recorded as +2020-00-00T00:00:00Z[7].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's main subject is recorded as immunotherapy[8].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's main subject is recorded as vaccine[9].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's main subject is recorded as mucosal associated invariant T cell[10].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's work available at URL is recorded as https://ourarchive.otago.ac.nz/handle/10523/10121[11].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's Handle ID is recorded as 10523/10121[12].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's title is recorded as Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy[13].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's copyright holder is recorded as Joshua Lange[14].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's thesis submitted to is recorded as University of Otago[15].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's on focus list of Wikimedia project is recorded as NZThesisProject[16].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's copyright status is recorded as copyrighted[17].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's thesis committee member is recorded as Brett Delahunt[18].
- Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's thesis committee member is recorded as Ian F Hermans[19].
Body
Designation and Status
Mucosal-associated invariant T (MAIT) cells as cellular adjuvants for cancer immunotherapy's instance of is recorded as doctoral thesis[3].